Rosetta Genomics Ltd. (NasdaqCM:ROSG) is seeking acquisitions. Rosetta Genomics Ltd. has filed a shelf registration in the amount of $7.5 million. Rosetta Genomics, said, “We intend to use the net proceeds from the sale of securities under this prospectus for our operations and for other general corporate purposes, including, but not limited to, repayment or refinancing of indebtedness or other corporate borrowings, working capital, intellectual property protection and enforcement, capital expenditures, investments, acquisitions or collaborations, research and development and product development.”